Cargando…
Design and synthesis of benzodiazepines as brain penetrating PARP-1 inhibitors
The poly (ADP-ribose) polymerase (PARP) inhibitors play a crucial role in cancer therapy. However, most approved PARP inhibitors cannot cross the blood-brain barrier, thus limiting their application in the central nervous system. Here, 55 benzodiazepines were designed and synthesised to screen brain...
Autores principales: | Yu, Jiang, Gou, Wenfeng, Shang, Haihua, Cui, Yating, Sun, Xiao, Luo, Lingling, Hou, Wenbin, Sun, Tiemin, Li, Yiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942544/ https://www.ncbi.nlm.nih.gov/pubmed/35317687 http://dx.doi.org/10.1080/14756366.2022.2053524 |
Ejemplares similares
-
Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
por: Wei, Huiqiang, et al.
Publicado: (2016) -
Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020) -
Design, Synthesis and Molecular Modeling Study of Conjugates of ADP and Morpholino Nucleosides as A Novel Class of Inhibitors of PARP-1, PARP-2 and PARP-3
por: Sherstyuk, Yuliya V., et al.
Publicado: (2019) -
Design and Synthesis
of Brain Penetrant Trypanocidal N-Myristoyltransferase
Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017) -
Design, Synthesis and Biological Evaluation of Sulfamide and Triazole Benzodiazepines as Novel p53-MDM2 Inhibitors
por: Yu, Zhiliang, et al.
Publicado: (2014)